QQQ   287.64 (-1.68%)
AAPL   146.63 (-0.80%)
MSFT   250.20 (-1.89%)
META   122.43 (-0.86%)
GOOGL   99.48 (-0.96%)
AMZN   91.01 (-3.31%)
TSLA   182.45 (-6.37%)
NVDA   166.10 (-1.58%)
NIO   12.80 (-2.51%)
BABA   90.52 (+0.51%)
AMD   73.62 (-1.81%)
T   18.75 (-1.42%)
MU   54.04 (-1.17%)
CGC   4.32 (+0.70%)
F   13.38 (-3.46%)
GE   84.66 (-2.56%)
DIS   95.93 (-3.52%)
AMC   7.45 (-8.81%)
PYPL   73.62 (-1.39%)
PFE   50.73 (-0.35%)
NFLX   312.59 (-2.44%)
QQQ   287.64 (-1.68%)
AAPL   146.63 (-0.80%)
MSFT   250.20 (-1.89%)
META   122.43 (-0.86%)
GOOGL   99.48 (-0.96%)
AMZN   91.01 (-3.31%)
TSLA   182.45 (-6.37%)
NVDA   166.10 (-1.58%)
NIO   12.80 (-2.51%)
BABA   90.52 (+0.51%)
AMD   73.62 (-1.81%)
T   18.75 (-1.42%)
MU   54.04 (-1.17%)
CGC   4.32 (+0.70%)
F   13.38 (-3.46%)
GE   84.66 (-2.56%)
DIS   95.93 (-3.52%)
AMC   7.45 (-8.81%)
PYPL   73.62 (-1.39%)
PFE   50.73 (-0.35%)
NFLX   312.59 (-2.44%)
QQQ   287.64 (-1.68%)
AAPL   146.63 (-0.80%)
MSFT   250.20 (-1.89%)
META   122.43 (-0.86%)
GOOGL   99.48 (-0.96%)
AMZN   91.01 (-3.31%)
TSLA   182.45 (-6.37%)
NVDA   166.10 (-1.58%)
NIO   12.80 (-2.51%)
BABA   90.52 (+0.51%)
AMD   73.62 (-1.81%)
T   18.75 (-1.42%)
MU   54.04 (-1.17%)
CGC   4.32 (+0.70%)
F   13.38 (-3.46%)
GE   84.66 (-2.56%)
DIS   95.93 (-3.52%)
AMC   7.45 (-8.81%)
PYPL   73.62 (-1.39%)
PFE   50.73 (-0.35%)
NFLX   312.59 (-2.44%)
QQQ   287.64 (-1.68%)
AAPL   146.63 (-0.80%)
MSFT   250.20 (-1.89%)
META   122.43 (-0.86%)
GOOGL   99.48 (-0.96%)
AMZN   91.01 (-3.31%)
TSLA   182.45 (-6.37%)
NVDA   166.10 (-1.58%)
NIO   12.80 (-2.51%)
BABA   90.52 (+0.51%)
AMD   73.62 (-1.81%)
T   18.75 (-1.42%)
MU   54.04 (-1.17%)
CGC   4.32 (+0.70%)
F   13.38 (-3.46%)
GE   84.66 (-2.56%)
DIS   95.93 (-3.52%)
AMC   7.45 (-8.81%)
PYPL   73.62 (-1.39%)
PFE   50.73 (-0.35%)
NFLX   312.59 (-2.44%)
NASDAQ:TWST

Twist Bioscience - TWST Stock Forecast, Price & News

$27.74
-0.76 (-2.67%)
(As of 12/5/2022 12:00 AM ET)
Add
Compare
Today's Range
$27.46
▼
$28.74
50-Day Range
$24.60
▼
$39.37
52-Week Range
$23.90
▼
$92.22
Volume
1.21 million shs
Average Volume
1.08 million shs
Market Capitalization
$1.57 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$40.25

Twist Bioscience MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.50 Rating Score
Upside/​Downside
45.1% Upside
$40.25 Price Target
Short Interest
Bearish
10.75% of Shares Sold Short
Dividend Strength
N/A
Sustainability
-1.42
Upright™ Environmental Score
News Sentiment
N/A
Insider Trading
Selling Shares
$341,371 Sold Last Quarter
Proj. Earnings Growth
Growing
From ($4.53) to ($3.73) Per Share

Overall MarketRank™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.12 out of 5 stars

Medical Sector

472nd out of 1,033 stocks

Biological Products, Except Diagnostic Industry

78th out of 170 stocks

See Top Rated MarketRank™ Stocks Here
TWST stock logo

About Twist Bioscience (NASDAQ:TWST) Stock

Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for drug discovery and development, and DNA as a digital data storage medium. The company has collaboration agreements with Victorian Clinical Genetic Services; Vivlion GmbH.; Kyowa Kirin Pharmaceutical Research, Inc.; deepCDR Biologics AG; and Centogene N.V to develop advanced sequencing tools. It also has a research collaboration with Boehringer Ingelheim International GmbH to use proprietary antibody libraries to discover therapeutic antibodies against multiple targets. Twist Bioscience Corporation was incorporated in 2013 and is headquartered in South San Francisco, California.

Receive TWST Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Twist Bioscience and its competitors with MarketBeat's FREE daily newsletter.

TWST Stock News Headlines

December 3, 2022 | wsj.com
Bragar Eagel & Squire, P.C. Is Investigating Veru, Twist, and Leidos and Encourages Investors to Contact the Firm
November 28, 2022 | americanbankingnews.com
Head to Head Review: Forma Therapeutics (NASDAQ:FMTX) vs. Twist Bioscience (NASDAQ:TWST)
November 24, 2022 | benzinga.com
TWST Shareholder Alert: KAPLAN FOX Announces Investigation of Twist Bioscience Corp. for Potential Securities Fraud
November 20, 2022 | finance.yahoo.com
Twist Bioscience Full Year 2022 Earnings: EPS Beats Expectations
November 16, 2022 | benzinga.com
SHAREHOLDER ALERT: Investigation of Twist Bioscience Corporation (TWST) Announced By Nationally Ranked Investors' Rights Firm Holzer & Holzer, LLC
November 15, 2022 | finance.yahoo.com
Twist Bioscience shares slide 20% after short seller compares synthetic DNA provider to Theranos, calling it a ‘cash-burning inferno’
November 15, 2022 | finance.yahoo.com
Twist Bioscience Addresses Misleading Short-Seller Report
November 15, 2022 | investorplace.com
Why Is Twist Bioscience (TWST) Stock Down 18% Today?
November 15, 2022 | finance.yahoo.com
Twist Bioscience's stock falls 18% after short seller calls the company a 'cash-burning inferno'
November 14, 2022 | finance.yahoo.com
Twist Bioscience (TWST) Surges 16.1%: Is This an Indication of Further Gains?
November 11, 2022 | seekingalpha.com
Twist Bioscience: Cash Burn Continues To Be The Issue
November 3, 2022 | finance.yahoo.com
Twist Bioscience to Report Fiscal 2022 Fourth Quarter and Full Year Financial Results on Friday, November 18, 2022
October 18, 2022 | finance.yahoo.com
The past year for Twist Bioscience (NASDAQ:TWST) investors has not been profitable
October 7, 2022 | finance.yahoo.com
Got $2,000? Consider Buying These 2 Beaten-Down Cathie Wood Stocks at Your Own Risk
October 6, 2022 | markets.businessinsider.com
Where Twist Bioscience Stands With Analysts
October 5, 2022 | finance.yahoo.com
Twist Bioscience to Present at JSNN NanoImpacts 2022
October 2, 2022 | nypost.com
Kadarius Toney downgraded on injury report in Giants twist
September 25, 2022 | abcnews.go.com
New twist in Pogba extortion probe, with brother's videos
September 20, 2022 | finance.yahoo.com
The Australian Research Council Centre of Excellence in Synthetic Biology and Twist Bioscience Partner to Foster and Accelerate Synthetic Biology Research in Australia
August 19, 2022 | benzinga.com
Twist Bioscience Chief Financial Officer Sold $687K In Company Stock
August 18, 2022 | finance.yahoo.com
10 Cathie Wood Stocks to Buy Before the Bull Run Starts
August 16, 2022 | finance.yahoo.com
California biotech's $100M investment in Oregon is on track
August 10, 2022 | finance.yahoo.com
Twist Bioscience (TWST) Upgraded to Buy: What Does It Mean for the Stock?
August 8, 2022 | finance.yahoo.com
10 Healthcare Stocks Making Moves After Earnings
August 5, 2022 | finance.yahoo.com
Twist Bioscience Q3 Sales Jump 60%, Raises FY22 Revenue Outlook Surpassing Consensus
See More Headlines
Receive TWST Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Twist Bioscience and its competitors with MarketBeat's FREE daily newsletter.

TWST Company Calendar

Last Earnings
11/22/2021
Today
12/05/2022
Next Earnings (Estimated)
2/02/2023
Fiscal Year End
9/30/2023
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Biological products, except diagnostic
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:TWST
CUSIP
N/A
CIK
1581280
Web
www.twistbioscience.com
Phone
(800) 719-0671
Fax
N/A
Employees
652
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$40.25
High Stock Price Forecast
$55.00
Low Stock Price Forecast
$30.00
Forecasted Upside/Downside
+45.1%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.50
Research Coverage
4 Analysts

Profitability

EPS (Most Recent Fiscal Year)
($4.03)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-217,860,000.00
Net Margins
-107.02%
Pretax Margin
-112.14%
Return on Equity
-28.89%
Return on Assets
-23.89%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
6.58
Quick Ratio
6.15

Sales & Book Value

Annual Sales
$203.57 million
Price / Sales
7.71
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$14.01 per share
Price / Book
1.98

Miscellaneous

Outstanding Shares
56,568,000
Free Float
54,814,000
Market Cap
$1.57 billion
Optionable
Not Optionable
Beta
1.07

Key Executives

  • Dr. Emily Marine Leproust Ph.D. (Age 49)
    Co-Founder, Chairman & CEO
    Comp: $1.28M
  • Dr. Patrick John Finn Ph.D.Dr. Patrick John Finn Ph.D. (Age 50)
    Pres & COO
    Comp: $726.35k
  • Mr. James M. ThorburnMr. James M. Thorburn (Age 66)
    Chief Financial Officer
    Comp: $771.71k
  • Dr. William Charles Banyai Ph.D. (Age 67)
    Sr. VP of Advanced Devel., GM of Data Storage & Director
    Comp: $628.12k
  • Mr. Kevin B. Yankton (Age 55)
    VP & Chief Accounting Officer
  • Mr. Siyuan Chen
    Chief Technology Officer
  • Dr. Aaron K. Sato Ph.D.
    Chief Scientific Officer
  • Mr. Dennis Cho (Age 51)
    Sr. VP, Gen. Counsel, Chief Ethics & Compliance Officer
  • Ms. Paula GreenMs. Paula Green (Age 54)
    Sr. VP of HR
  • Ms. Erin Smith
    Sr. VP of Gov. Affairs & Public Policy

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions













TWST Stock - Frequently Asked Questions

Should I buy or sell Twist Bioscience stock right now?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Twist Bioscience in the last year. There are currently 2 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" TWST shares.
View TWST analyst ratings or view top-rated stocks.

What is Twist Bioscience's stock price forecast for 2023?

4 Wall Street research analysts have issued 1 year price objectives for Twist Bioscience's stock. Their TWST share price forecasts range from $30.00 to $55.00. On average, they anticipate the company's stock price to reach $40.25 in the next twelve months. This suggests a possible upside of 45.1% from the stock's current price.
View analysts price targets for TWST or view top-rated stocks among Wall Street analysts.

How have TWST shares performed in 2022?

Twist Bioscience's stock was trading at $77.39 at the beginning of 2022. Since then, TWST stock has decreased by 64.2% and is now trading at $27.74.
View the best growth stocks for 2022 here.

When is Twist Bioscience's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, February 2nd 2023.
View our TWST earnings forecast.

How were Twist Bioscience's earnings last quarter?

Twist Bioscience Co. (NASDAQ:TWST) posted its quarterly earnings results on Monday, November, 22nd. The company reported ($0.84) earnings per share for the quarter, missing the consensus estimate of ($0.80) by $0.04. The business had revenue of $37.95 million for the quarter, compared to the consensus estimate of $36.26 million. Twist Bioscience had a negative net margin of 107.02% and a negative trailing twelve-month return on equity of 28.89%. The business's revenue was up 17.0% on a year-over-year basis. During the same quarter in the prior year, the business posted ($0.54) earnings per share.

What guidance has Twist Bioscience issued on next quarter's earnings?

Twist Bioscience updated its FY 2023 earnings guidance on Friday, November, 18th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $261.00 million-$269.00 million, compared to the consensus revenue estimate of $256.22 million.

What is Emily Leproust's approval rating as Twist Bioscience's CEO?

44 employees have rated Twist Bioscience Chief Executive Officer Emily Leproust on Glassdoor.com. Emily Leproust has an approval rating of 83% among the company's employees.

What other stocks do shareholders of Twist Bioscience own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Twist Bioscience investors own include CrowdStrike (CRWD), Pfizer (PFE), DocuSign (DOCU), Intel (INTC), NVIDIA (NVDA), Advanced Micro Devices (AMD), Gilead Sciences (GILD), JD.com (JD), Tesla (TSLA) and Twilio (TWLO).

When did Twist Bioscience IPO?

(TWST) raised $75 million in an IPO on Wednesday, October 31st 2018. The company issued 5,000,000 shares at $14.00-$16.00 per share. J.P. Morgan and Cowen served as the underwriters for the IPO and Allen & Company and Baird were co-managers.

What is Twist Bioscience's stock symbol?

Twist Bioscience trades on the NASDAQ under the ticker symbol "TWST."

Who are Twist Bioscience's major shareholders?

Twist Bioscience's stock is owned by a variety of retail and institutional investors. Top institutional investors include ARK Investment Management LLC (11.85%), Vanguard Group Inc. (8.73%), BlackRock Inc. (8.70%), State Street Corp (5.08%), Sumitomo Mitsui Trust Holdings Inc. (5.00%) and Marshall Wace LLP (2.12%). Insiders that own company stock include Emily M Leproust, Emily M Leproust, James M Thorburn, Jan Johannessen, John P Molloy, Keith Crandell, Mark Daniels, Nicolas Barthelemy, Patrick John Finn, Patrick Weiss, Paula Green, Robert Chess and William Banyai.
View institutional ownership trends.

How do I buy shares of Twist Bioscience?

Shares of TWST stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Twist Bioscience's stock price today?

One share of TWST stock can currently be purchased for approximately $27.74.

How much money does Twist Bioscience make?

Twist Bioscience (NASDAQ:TWST) has a market capitalization of $1.57 billion and generates $203.57 million in revenue each year. The company earns $-217,860,000.00 in net income (profit) each year or ($4.03) on an earnings per share basis.

How many employees does Twist Bioscience have?

The company employs 652 workers across the globe.

How can I contact Twist Bioscience?

Twist Bioscience's mailing address is 681 GATEWAY BLVD., SOUTH SAN FRANCISCO CA, 94080. The official website for the company is www.twistbioscience.com. The company can be reached via phone at (800) 719-0671 or via email at maeve@argotpartners.com.

This page (NASDAQ:TWST) was last updated on 12/5/2022 by MarketBeat.com Staff